Cargando…

Association Between Aldehyde dehydrogenase-2 Polymorphisms and Risk of Alzheimer's Disease and Parkinson's Disease: A Meta-Analysis Based on 5,315 Individuals

Objective: A number of studies have reported that aldehyde dehydrogenase-2 (ALDH2) polymorphisms maybe associated with the risk of Alzheimer's disease (AD) and Parkinson's disease (PD). However, the results of such studies are inconsistent. We therefore conducted a meta-analysis to clarify...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Jun, Huang, Wei, Cheng, Chao-Hui, Zhou, Lan, Jiang, Guang-Bin, Hu, Yuan-Yuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6448532/ https://www.ncbi.nlm.nih.gov/pubmed/30984100 http://dx.doi.org/10.3389/fneur.2019.00290

Ejemplares similares

Association Study of Alcohol Dehydrogenase and Aldehyde Dehydrogenase Polymorphism With Alzheimer Disease in the Taiwanese Population
por: Wu, Yah-Yuan, et al.
Publicado: (2021)

Assessment of five different guideline indication criteria for spirometry, including modified GOLD criteria, in order to detect COPD: data from 5,315 subjects in the PLATINO study
por: Luize, Ana P, et al.
Publicado: (2014)

Aldehyde dehydrogenase 2 activity and aldehydic load contribute to neuroinflammation and Alzheimer’s disease related pathology
por: Joshi, Amit U., et al.
Publicado: (2019)

Benomyl, Aldehyde Dehydrogenase, DOPAL, and the Catecholaldehyde Hypothesis for the Pathogenesis of Parkinson’s Disease
por: Casida, John E., et al.
Publicado: (2014)

Aldehyde dehydrogenase 2 is associated with cognitive functions in patients with Parkinson’s disease
por: Yu, Rwei-Ling, et al.
Publicado: (2016)

Association of Aldehyde Dehydrogenase 2 Gene Polymorphism with Myocardial Infarction
por: Zhu, Li-Ping, et al.
Publicado: (2021)

Mitochondrial aldehyde dehydrogenase and cardiac diseases
por: Chen, Che-Hong, et al.
Publicado: (2010)

Aldehyde Dehydrogenase, Liver Disease and Cancer
por: Wang, Wenjun, et al.
Publicado: (2020)

Metal Exposure and SNCA rs356219 Polymorphism Associated With Parkinson Disease and Parkinsonism
por: Lucchini, Roberto G., et al.
Publicado: (2020)

Does in-vehicle automation help individuals with Parkinson’s disease? A preliminary analysis
por: Giang, Wayne C.W., et al.
Publicado: (2023)

Aldehyde dehydrogenase 2 rs671G>A polymorphism and ischemic stroke risk in Chinese population: a meta-analysis
por: Xu, Yue-Long, et al.
Publicado: (2019)

Methodological Issues in Randomized Clinical Trials for Prodromal Alzheimer's and Parkinson's Disease
por: de Aquino, Camila Henriques
Publicado: (2021)

Association of SNCA Parkinson's Disease Risk Polymorphisms With Disease Progression in Newly Diagnosed Patients
por: Szwedo, Aleksandra A., et al.
Publicado: (2021)

Neurodegeneration and Motor Dysfunction in Mice Lacking Cytosolic and Mitochondrial Aldehyde Dehydrogenases: Implications for Parkinson's Disease
por: Wey, Margaret Chia-Ying, et al.
Publicado: (2012)

Leveraging the Potential of Digital Technology for Better Individualized Treatment of Parkinson's Disease
por: Fröhlich, Holger, et al.
Publicado: (2022)

SLC6A3 Polymorphism Predisposes to Dopamine Overdose in Parkinson's Disease
por: Robertson, Brian D., et al.
Publicado: (2018)

Role of aldehyde dehydrogenase 2 Glu504lys polymorphism in acute coronary syndrome
por: Xu, Feng, et al.
Publicado: (2011)

Ketogenic interventions in mild cognitive impairment, Alzheimer's disease, and Parkinson's disease: A systematic review and critical appraisal
por: Bohnen, Jeffrey L. B., et al.
Publicado: (2023)

Association of alcohol dehydrogenase and aldehyde dehydrogenase Polymorphism with Spontaneous Deep Intracerebral Haemorrhage in the Taiwan population
por: Huang, Yu-Hua, et al.
Publicado: (2020)

Associations of Alcohol Dehydrogenase and Aldehyde Dehydrogenase Polymorphism With Cognitive Impairment Among the Oldest-Old in China
por: Jin, Xurui, et al.
Publicado: (2022)

First Symptoms of Primary Progressive Aphasia and Alzheimer's Disease in Brazilian Individuals
por: dos Reis, Talita Gallas, et al.
Publicado: (2021)

Alcohol dehydrogenase and aldehyde dehydrogenase in malignant neoplasms
por: Orywal, Karolina, et al.
Publicado: (2016)

Tau Pathology in Parkinson's Disease
por: Zhang, Xue, et al.
Publicado: (2018)

Improvement of Deep Brain Stimulation in Dyskinesia in Parkinson's Disease: A Meta-Analysis
por: Liu, Yun, et al.
Publicado: (2019)

Monitoring Motor Symptoms During Activities of Daily Living in Individuals With Parkinson's Disease
por: Thorp, Jenna E., et al.
Publicado: (2018)

Association of Two Polymorphisms in CCL2 With Parkinson's Disease: A Case-Control Study
por: Shen, Ruinan, et al.
Publicado: (2019)

The Trajectory of Motor Deterioration to Death in Parkinson's Disease
por: Poonja, Sabrina, et al.
Publicado: (2021)

Functional polymorphism in aldehyde dehydrogenase-2 gene associated with risk of tuberculosis
por: Park, Seung Kyu, et al.
Publicado: (2014)

Aldehyde dehydrogenase 2 rs671 polymorphism and multiple diseases: protocol for a quantitative umbrella review of meta-analyses
por: He, Zhengting, et al.
Publicado: (2022)

Glu504Lys Single Nucleotide Polymorphism of Aldehyde Dehydrogenase 2 Gene and the Risk of Human Diseases
por: Zhao, Yan, et al.
Publicado: (2015)

Musculoskeletal Pain in Parkinson's Disease
por: Li, Jun, et al.
Publicado: (2022)

Research methods and efficacy of acupuncture in the treatment of Parkinson's disease: a scoping review of systematic reviews and meta-analyses
por: Yu, Bin, et al.
Publicado: (2023)

Effect of alcohol and aldehyde dehydrogenase gene polymorphisms on alcohol-associated hypertension: the Guangzhou Biobank Cohort Study
por: Sen Zhang, Wei, et al.
Publicado: (2013)

Editorial: Neuroimaging in Parkinson's disease and Parkinsonism
por: Zhang, Yu, et al.
Publicado: (2023)

Longitudinal evaluation of olfactory function in individuals with Gaucher disease and GBA1 mutation carriers with and without Parkinson's disease
por: Lopez, Grisel J., et al.
Publicado: (2022)

Aldehyde Dehydrogenase 1 making molecular inroads into the differential vulnerability of nigrostriatal dopaminergic neuron subtypes in Parkinson’s disease
por: Cai, Huaibin, et al.
Publicado: (2014)

Corrigendum: Association of Two Polymorphisms in CCL2 With Parkinson's Disease: A Case-Control Study
por: Shen, Ruinan, et al.
Publicado: (2019)

Polymorphism of the Dopa-Decarboxylase Gene Modifies the Motor Response to Levodopa in Chinese Patients With Parkinson's Disease
por: Li, Lanting, et al.
Publicado: (2020)

Lower Limb Resistance Training in Individuals With Parkinson's Disease: An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Li, Xiaoyan, et al.
Publicado: (2020)

Neurophthalmologic and Orthoptic Ambulatory Assessments Reveal Ocular and Visual Changes in Patients With Early Alzheimer and Parkinson's Disease
por: Bargagli, Alessia, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_q982t2en23bg216fherd5q903a